Volker Gerdts | Director And Chief Executive Officer
VIDO-InterVac | Canada

Volker Gerdts, Director And Chief Executive Officer, VIDO-InterVac

Dr. Volker Gerdts is the Associate Director of Research at the Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac), University of Saskatchewan in Saskatoon, SK Canada.  Dr. Volker Gerdts received a DVM in 1994 from Hanover Veterinary School and a German PhD equivalent from the Federal Research Institute for Animal Health, Island of Riems and Hanover Veterinary School, Germany in 1997.  

He has served in various administrative roles and served on various review panels including NSERC, CIHR, CFI, SHRF, NIH, the Gairdner Foundation, etc.  Dr. Gerdts is a member of two editorial boards and an ad-hoc reviewer for various journals. 

Dr. Gerdts’ research interests are in the area of neonatal vaccines for humans and animals, mucosal immunology, and vaccine delivery and formulation.   Current research projects are focused on the development of novel adjuvants, the development of vaccines for PEDv and PRRSV, the use of pigs as model for humans, immune modulation and regulation of mucosal immune responses.

Appearances:



Oct 28th Pre-Congress Workshops @ 14:00

Workshop C: Active & passive immunity: How do we induce maternal immunisation in human and animals?

Maternal immunity plays a pivotal role in human & animal health, but what do we understand?Is the veterinary vaccine industry more advanced than human? What can we learn from each other to move the field forward?

Placental antibody transfer: protecting infants against respiratory diseases Where are we with respiratory vaccines and maternal immunity?Protection of neonates and infants by maternal immunizationColostral and lactogenic immunity against viral diseases in pigs - how to protect the offspring by immunisation of the motherTransfer of maternal immunity from a swine perspective
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates